Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1985 Nov 1;162(5):1683–1694. doi: 10.1084/jem.162.5.1683

Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells

PMCID: PMC2187930  PMID: 2932519

Abstract

DA rats grafted with major histocompatibility complex-incompatible PVG heart grafts and treated with cyclosporine (CY) for 10 d do not reject their grafts, and develop a state of specific unresponsiveness toward PVG allografts. Cells from these animals tested in an adoptive transfer assay were incapable of restoring PVG graft rejection, and capable of specifically inhibiting the capacity of adoptively transferred normal lymph node cells (LNC) to do so. They effected third party Wistar/Furth (W/F) graft rejection, however. Adoptive transfer assays with purified subpopulations of the lymphocytes that mediated this effect showed that W3/25+ T cells of the helper/inducer subclass, when injected alone, failed to restore rejection, and were also able, when injected with normal LNC or the W/25+ cells separated from them, to prevent these cells from effecting rejection. MRC OX8+ T cells of the cytotoxic/suppressor subclass, B cells, and serum from rats with long- surviving grafts all failed to inhibit the allograft responsiveness of normal LNC, and thus were not identified as mediators of the state of specific unresponsiveness. These results show that the specific unresponsiveness that develops in rats with long-surviving grafts, and which, in part at least, is responsible for prolonged graft survival, is due to an alteration in the alloreactivity of the helper/inducer subclass of T cells. These cells not only lack the capacity to initiate a rejection response against the alloantigens of the graft, but also have the ability to inhibit the capacity of normal W3/25+ cells to do so.

Full Text

The Full Text of this article is available as a PDF (767.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bordes-Aznar J., Kupiec-Weglinski J. W., Duarte A. J., Milford E. L., Strom T. B., Tilney N. L. Function and migration of suppressor lymphocytes from cyclosporine-treated heart graft recipients. Transplantation. 1983 Feb;35(2):185–190. doi: 10.1097/00007890-198302000-00015. [DOI] [PubMed] [Google Scholar]
  2. Borel J. F., Feurer C., Magnée C., Stähelin H. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology. 1977 Jun;32(6):1017–1025. [PMC free article] [PubMed] [Google Scholar]
  3. Dorf M. E., Benacerraf B. Suppressor cells and immunoregulation. Annu Rev Immunol. 1984;2:127–157. doi: 10.1146/annurev.iy.02.040184.001015. [DOI] [PubMed] [Google Scholar]
  4. Elmets C. A., Bergstresser P. R., Tigelaar R. E., Wood P. J., Streilein J. W. Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation. J Exp Med. 1983 Sep 1;158(3):781–794. doi: 10.1084/jem.158.3.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fabre J. W., Morris P. J. The mechanism of specific immunosuppression of renal allograft rejection by donor strain blood. Transplantation. 1972 Nov;14(5):634–640. doi: 10.1097/00007890-197211000-00016. [DOI] [PubMed] [Google Scholar]
  6. Hall B. M., Dorsch S., Roser B. The cellular basis of allograft rejection in vivo. I. The cellular requirements for first-set rejection of heart grafts. J Exp Med. 1978 Oct 1;148(4):878–889. doi: 10.1084/jem.148.4.878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hall B. M., Jelbart M. E., Dorsch S. E. Suppressor T cells in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Transplantation. 1984 Jun;37(6):595–600. doi: 10.1097/00007890-198406000-00014. [DOI] [PubMed] [Google Scholar]
  8. Hall B. M. Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell. J Exp Med. 1985 Jan 1;161(1):123–133. doi: 10.1084/jem.161.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hall B. M. Mechanisms of specific unresponsiveness to allografts. Transplant Proc. 1984 Aug;16(4):938–943. [PubMed] [Google Scholar]
  10. Hall B. M., Roser B. J., Dorsch S. E. A model for study of the cellular mechanisms that maintain long-term enhancement of cardiac graft survival. Transplant Proc. 1979 Mar;11(1):958–961. [PubMed] [Google Scholar]
  11. Hall B. M., de Saxe I., Dorsch S. E. The cellular basis of allograft rejection in vivo. III. Restoration of first-set rejection of heart grafts by T helper cells in irradiated rats. Transplantation. 1983 Dec;36(6):700–705. doi: 10.1097/00007890-198336060-00023. [DOI] [PubMed] [Google Scholar]
  12. Hess A. D., Tutschka P. J. Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR. J Immunol. 1980 Jun;124(6):2601–2608. [PubMed] [Google Scholar]
  13. Holán V., Mitchison N. A. Haplotype-specific suppressor T cells mediating linked suppression of immune responses elicited by third-party H-2 alloantigens. Eur J Immunol. 1983 Aug;13(8):652–657. doi: 10.1002/eji.1830130809. [DOI] [PubMed] [Google Scholar]
  14. Hutchinson I. F., Shadur C. A., Duarte J. S., Strom T. B., Tilney N. L. Cyclosporin A spares selectively lymphocytes with donor-specific suppressor characteristics. Transplantation. 1981 Sep;32(3):210–216. doi: 10.1097/00007890-198109000-00006. [DOI] [PubMed] [Google Scholar]
  15. Kunkl A., Klaus G. G. Selective effects of cyclosporin A on functional B cell subsets in the mouse. J Immunol. 1980 Dec;125(6):2526–2531. [PubMed] [Google Scholar]
  16. Larsson E. L. Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process. J Immunol. 1980 Jun;124(6):2828–2833. [PubMed] [Google Scholar]
  17. Leapman S. B., Filo R. S., Smith E. J., Smith P. G. In vitro effects of cyclosporin A on lymphocyte subpopulations. 1. Suppressor cell sparing by cyclosporin A. Transplantation. 1980 Dec;30(6):404–408. doi: 10.1097/00007890-198012000-00003. [DOI] [PubMed] [Google Scholar]
  18. Loveland B. E., Hogarth P. M., Ceredig R., McKenzie I. F. Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med. 1981 May 1;153(5):1044–1057. doi: 10.1084/jem.153.5.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Macphail S., Stutman O. Suppressor T cells activated in a primary in vitro response to non-major histocompatibility alloantigens. J Exp Med. 1982 Nov 1;156(5):1398–1414. doi: 10.1084/jem.156.5.1398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Morris P. J. Suppression of rejection of organ allografts by alloantibody. Immunol Rev. 1980;49:93–125. doi: 10.1111/j.1600-065x.1980.tb00428.x. [DOI] [PubMed] [Google Scholar]
  21. North R. J., Bursuker I. Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells. J Exp Med. 1984 May 1;159(5):1295–1311. doi: 10.1084/jem.159.5.1295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ono K., Lindsey E. S. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg. 1969 Feb;57(2):225–229. [PubMed] [Google Scholar]
  23. Rolink A. G., Gleichmann E. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes. J Exp Med. 1983 Aug 1;158(2):546–558. doi: 10.1084/jem.158.2.546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stuart F. P., McKearn T. J., Weiss A., Fitch F. W. Suppression of rat renal allograft rejection by antigen and antibody. Immunol Rev. 1980;49:127–165. doi: 10.1111/j.1600-065x.1980.tb00429.x. [DOI] [PubMed] [Google Scholar]
  25. Tilney N. L., Kupiec-Weglinski J. W., Heidecke C. D., Lear P. A., Strom T. B. Mechanisms of rejection and prolongation of vascularized organ allografts. Immunol Rev. 1984;77:185–216. doi: 10.1111/j.1600-065x.1984.tb00722.x. [DOI] [PubMed] [Google Scholar]
  26. Wood M. L., Monaco A. P. Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice. Transplantation. 1980 Mar;29(3):196–200. doi: 10.1097/00007890-198003000-00006. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES